Isolation of Reovirus T3D Mutants Capable of Infecting Human Tumor Cells Independent of Junction Adhesion Molecule-A

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  van den Wollenberg, Diana J M ^a   Dautzenberg, Iris J C ^a   van den Hengel, Sanne K ^a   Cramer, Steve J ^a   de Groot, Raoul J ^b   Hoeben, Rob C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; JUNCTIONAL ADHESION MOLECULE A; SIALIC ACID; VIRUS SPIKE PROTEIN; WHEAT GERM AGGLUTININ;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL SURFACE; CHO CELL; CONTROLLED STUDY; FIBROBLAST; GLIOBLASTOMA; HUMAN; HUMAN CELL; MAMMALIAN ORTHOREOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN EXPRESSION; TUMOR CELL; VIRUS CHARACTERIZATION; VIRUS ISOLATION; VIRUS MUTANT; VIRUS RESISTANCE;

ANIMALS; CELL ADHESION MOLECULES; CELL LINE; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; CYSTEINE PROTEINASE INHIBITORS; GLIOBLASTOMA; HOST SPECIFICITY; HOST-PATHOGEN INTERACTIONS; HUMANS; LEUCINE; MAMMALIAN ORTHOREOVIRUS 3; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS; ONCOLYTIC VIROTHERAPY; PROTEIN MULTIMERIZATION; RECEPTORS, CELL SURFACE; RECEPTORS, VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS; VIRUS INTERNALIZATION;

CRICETINAE; MAMMALIA; MAMMALIAN ORTHOREOVIRUS 3; MURINAE; ORTHOREOVIRUS; RNA VIRUSES; TRITICUM AESTIVUM;

EID: 84868103303     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048064     Document Type: Article

References (62)

1. Coffey MC, Strong JE, Forsyth PA, Lee PW, (1998) Reovirus therapy of tumors with activated Ras pathway. Science 282: 1332-1334.
2. Norman KL, Lee PW, (2005) Not all viruses are bad guys: the case for reovirus in cancer therapy. Drug Discov Today 10: 847-855.
3. Strong JE, Coffey MC, Tang D, Sabinin P, Lee PW, (1998) The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. The EMBO journal 17: 3351-3362.
4. Tyler KL, Fields BN (2001) Mammalian Reoviruses. In: Knipe DM, Howely PM, editors. Philadelphia: Lippincott Williams & Wilkins. 1729-1745.
5. Barton ES, Chappell JD, Connolly JL, Forrest JC, Dermody TS, (2001) Reovirus receptors and apoptosis. Virology 290: 173-180.
6. Connolly JL, Barton ES, Dermody TS, (2001) Reovirus binding to cell surface sialic acid potentiates virus-induced apoptosis. J Virol 75: 4029-4039.
7. Kim M, Chung YH, Johnston RN, (2007) Reovirus and tumor oncolysis. JM 45: 187-192.
8. Norman KL, Hirasawa K, Yang AD, Shields MA, Lee PW, (2004) Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection. Proc Natl Acad Sci U S A 101: 11099-11104.
9. Smakman N, Van Den Wollenberg DJM, Borel Rinkes IHM, Hoeben RC, Kranenburg O, (2005) Sensitization to apoptosis underlies KrasD12-dependent oncolysis of murine C26 colorectal carcinoma cells by reovirus T3D. J Virol 79: 14981-14985.
10. Forsyth P, Roldan G, George D, Wallace C, Palmer CA, et al. (2008) A Phase I Trial of Intratumoral Administration of Reovirus in Patients With Histologically Confirmed Recurrent Malignant Gliomas. Mol Ther 16: 627-632.
11. Vidal L, Pandha HS, Yap TA, White CL, Twigger K, et al. (2008) A phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancer. Clin Cancer Res 14: 7127-7137.
12. Gollamudi R, Ghalib MH, Desai KK, Chaudhary I, Wong B, et al. (2010) Intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumors. Invest New Drugs 28: 641-649.
13. White CL, Twigger KR, Vidal L, De Bono JS, Coffey M, et al. (2008) Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial. Gen Ther 15: 911-920.
14. O'Donnell SM, Hansberger MW, Dermody TS, (2003) Viral and cellular determinants of apoptosis induced by mammalian reovirus. Int Rev Immunol 22: 477-503.
15. Barton ES, Connolly JL, Forrest JC, Chappell JD, Dermody TS, (2001) Utilization of sialic acid as a coreceptor enhances reovirus attachment by multistep adhesion strengthening. J Biol Chem 276: 2200-2211.
16. Guglielmi KM, Johnson EM, Stehle T, Dermody TS, (2006) Attachment and cell entry of mammalian orthoreovirus. Curr Top Microbiol Immunol 309: 1-38.
17. Maginnis MS, Forrest JC, Kopecky-Bromberg SA, Dickeson SK, Santoro SA, et al. (2006) Beta1 integrin mediates internalization of mammalian reovirus. J Virol 80: 2760-2770.
18. Alain T, Kim TS, Lun X, Liacini A, Schiff LA, et al. (2007) Proteolytic disassembly is a critical determinant for reovirus oncolysis. Mol Ther 15: 1512-1521.
19. Borsa J, Morash BD, Sargent MD, Copps TP, Lievaart PA, et al. (1979) Two modes of entry of reovirus particles into L cells. J Gen Vir 45: 161-170.
20. Mandell KJ, Parkos CA, (2005) The JAM family of proteins. Adv Drug Deliv Rev 57: 857-867.
21. Gutwein P, Schramme A, Voss B, Abdel-Bakky MS, Doberstein K, et al. (2009) Downregulation of junctional adhesion molecule-A is involved in the progression of clear cell renal cell carcinoma. Biochem Biophys Res Commun 380: 387-391.
22. Smakman N (2006) Human colorectal liver metastases are resistant to Reovirus T3D and display aberrant localization of the reovirus receptor JAM-1. Towards KRAS-directed therapy, Thesis, University Utrecht.
23. Naik MU, Naik TU, Suckow AT, Duncan MK, Naik UP, (2008) Attenuation of Junctional Adhesion Molecule-A Is a Contributing Factor for Breast Cancer Cell Invasion. Cancer Res 68: 2194-2203.
24. van Den Wollenberg DJM, Van Den Hengel SK, Dautzenberg IJC, Cramer SJ, Kranenburg O, et al. (2008) A strategy for genetic modification of the spike-encoding segment of human reovirus T3D for reovirus targeting. Gen Ther 15: 1567-15678.
25. Chappell JD, Gunn VL, Wetzel JD, Baer GS, Dermody TS, (1997) Mutations in type 3 reovirus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein sigma1. J Virol 71: 1834-1841.
26. Reiter DM, Frierson JM, Halvorson EE, Kobayashi T, Dermody TS, et al. (2011) Crystal Structure of Reovirus Attachment Protein-σ1 in Complex with Sialylated Oligosaccharides. PLoS Pathogens 7: e1002166.
27. Morris AP, Tawil A, Berkova Z, Wible L, Smith CW, et al. (2006) Junctional Adhesion Molecules (JAMs) are differentially expressed in fibroblasts and co-localize with ZO-1 to adherens-like junctions. Cell Commun Adhes 13: 233-247.
28. Barton ES, Forrest JC, Connolly JL, Chappell JD, Liu Y, et al. (2001) Junction adhesion molecule is a receptor for reovirus. Cell 104: 441-451.
29. Borsa J, Sargent MD, Lievaart PA, Copps TP, (1981) Reovirus: evidence for a second step in the intracellular uncoating and transcriptase activation process. Virology 111: 191-200.
30. Van Houdt WJ, Smakman N, van Den Wollenberg DJM, Emmink BL, Veenendaal LM, et al. (2008) Transient infection of freshly isolated human colorectal tumor cells by reovirus T3D intermediate subviral particles. Cancer Gene Ther 15: 284-292.
31. Connolly JL, Dermody TS, (2002) Virion disassembly is required for apoptosis induced by reovirus. J Virol 76: 1632-1641.
32. Schelling P, Guglielmi KM, Kirchner E, Paetzold B, Dermody TS, et al. (2007) The reovirus sigma1 aspartic acid sandwich: a trimerization motif poised for conformational change. J Biol Chem 282: 11582-11589.
33. Leone G, Maybaum L, Lee PW, (1992) The reovirus cell attachment protein possesses two independently active trimerization domains: basis of dominant negative effects. Cell 71: 479-488.
34. Kawaguchi T, Nomura K, Hirayama Y, Kitagawa T, (1987) Establishment and characterization of a chicken hepatocellular carcinoma cell line, LMH. Cancer Res 47: 4460-4464.
35. Obeso J, Weber J, Auerbach R, (1990) A hemangioendothelioma-derived cell line: its use as a model for the study of endothelial cell biology. Lab Invest 63: 259-269.
36. Pontén J, Saksela E, (1967) Two established in vitro cell lines from human mesenchymal tumours. Int J Cancer 2: 434-447.
37. Kovar H, Jug G, Aryee DN, Zoubek A, Ambros P, et al. (1997) Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors. Oncogene 15: 2225-2232.
38. Rubin DH, Wetzel JD, Williams WV, Cohen JA, Dworkin C, et al. (1992) Binding of type 3 reovirus by a domain of the sigma 1 protein important for hemagglutination leads to infection of murine erythroleukemia cells. J Clin Invest 90: 2536-2542.
39. Arnberg N, Edlund K, Kidd AH, Wadell G, (2000) Adenovirus Type 37 Uses Sialic Acid as a Cellular Receptor. J Virol 74: 42-48.
40. Eckhardt M, Gotza B, Gerardy-Schahn R, (1998) Mutants of the CMP-sialic acid transporter causing the Lec2 phenotype. J Biol Chem 273: 20189-20195.
41. Danthi P, Hansberger MW, Campbell JA, Forrest JC, Dermody TS, (2006) JAM-A-independent, antibody-mediated uptake of reovirus into cells leads to apoptosis. J Virol 80: 1261-1270.
42. Campbell JA, Schelling P, Wetzel JD, Johnson EM, Forrest JC, et al. (2005) Junctional adhesion molecule a serves as a receptor for prototype and field-isolate strains of mammalian reovirus. J Virol 79: 7967-7978.
43. Kelly K, Nawrocki S, Mita A, Coffey M, Giles FJ, et al. (2009) Reovirus-based therapy for cancer. EOBT 9: 817-830.
44. Norman KL, Lee PW, (2000) Reovirus as a novel oncolytic agent. J Clin Invest 105: 1035-1038.
45. Koshiba H, Hosokawa K, Kubo A, Tokumitsu N, Watanabe A, et al. (2009) Junctional adhesion molecule A [corrected] expression in human endometrial carcinoma. Int J Gynecol Cancer 19: 208-213.
46. Byrnes AP, Griffin DE, (2000) Large-Plaque Mutants of Sindbis Virus Show Reduced Binding to Heparan Sulfate, Heightened Viremia, and Slower Clearance from the Circulation. J Virol 74: 644-651.
47. Hulst MM, van Gennip HG, Moormann RJ, (2000) Passage of classical swine fever virus in cultured swine kidney cells selects virus variants that bind to heparan sulfate due to a single amino acid change in envelope protein E(rns). J Virol 74: 9553-9561.
48. Sa-carvalho D, Reider E, Baxt B, Rodarte R, Tanuri A, et al. (1997) Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J Virol 71: 5115-5123.
49. Cardin AD, Weintraub HJ, (1989) Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9: 21-32.
50. Hileman RE, Fromm JR, Weiler JM, Linhardt RJ, (1998) Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. BioEssays 20: 156-167.
51. Vives RR, Lortat-Jacob H, Fender P, (2006) Heparan sulphate proteoglycans and viral vectors: ally or foe? Curr Gene Ther 6: 35-44.
52. Bernard K, Klimstra WB, Johnston RE, (2000) Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice. Virology 276: 93-103.
53. Bauer PH, Cui C, Liu WR, Stehle T, Harrison SC, et al. (1999) Discrimination between sialic acid-containing receptors and pseudoreceptors regulates polyomavirus spread in the mouse. J Virol 73: 5826-5832.
54. López-Bueno A, Rubio MP, Bryant N, McKenna R, Agbandje-McKenna M, et al. (2006) Host-selected amino acid changes at the sialic acid binding pocket of the parvovirus capsid modulate cell binding affinity and determine virulence. J Virol 80: 1563-1573.
55. Chandran K, Nibert ML, (2003) Animal cell invasion by a large nonenveloped virus: reovirus delivers the goods. Trends Microbiol 11: 374-382.
56. Jané-Valbuena J, Breun LA, Schiff LA, Nibert ML, (2002) Sites and determinants of early cleavages in the proteolytic processing pathway of reovirus surface protein sigma3. J Virol 76: 5184-5197.
57. Wilson GJ, Nason EL, Hardy CS, Ebert DH, Wetzel JD, et al. (2002) A single mutation in the carboxy terminus of reovirus outer-capsid protein sigma 3 confers enhanced kinetics of sigma 3 proteolysis, resistance to inhibitors of viral disassembly, and alterations in sigma 3 structure. J Virol 76: 9832-9843.
58. Tyler KL, (1998) Pathogenesis of reovirus infections of the central nervous system. Curr Top Microbiol Immunol 233: 93-124.
59. Klein B, Pastink A, Odijk H, Westerveld A, van Der Eb AJ, (1990) Transformation and immortalization of diploid xeroderma pigmentosum fibroblasts. Exp Cell Res 191: 256-262.
60. Smakman N, Van Den Wollenberg DJM, Elias SG, Sasazuki T, Shirasawa S, et al. (2006) KRAS(D13) Promotes apoptosis of human colorectal tumor cells by ReovirusT3D and oxaliplatin but not by tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 66: 5403-5408.
61. Virgin HW, Mann MA, Fields BN, Tyler KL, (1991) Monoclonal antibodies to reovirus reveal structure/function relationships between capsid proteins and genetics of susceptibility to antibody action. J Virol 65: 6772-6781.
62. Fallaux FJ, Kranenburg O, Cramer SJ, Houweling A, van Ormondt H, et al. (1996) Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gen Ther 7: 215-222.